SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-301292
Filing Date
2019-11-27
Accepted
2019-11-26 17:37:32
Documents
4
Period of Report
2019-11-26

Document Format Files

Seq Description Document Type Size
1 6-K d839897d6k.htm 6-K 45194
2 GRAPHIC g839897dsp01.jpg GRAPHIC 2926
3 GRAPHIC g839897dsp01a.jpg GRAPHIC 3447
4 GRAPHIC g839897g53j23.jpg GRAPHIC 6583
  Complete submission text file 0001193125-19-301292.txt   64588
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 191252352
SIC: 2834 Pharmaceutical Preparations